149 related articles for article (PubMed ID: 19921428)
21. Influence of glutathione S-transferase polymorphisms (GSTT1, GSTM1, GSTP1) on type-2 diabetes mellitus (T2D) risk in an endogamous population from north India.
Mastana SS; Kaur A; Hale R; Lindley MR
Mol Biol Rep; 2013 Dec; 40(12):7103-10. PubMed ID: 24203463
[TBL] [Abstract][Full Text] [Related]
22. GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis.
Wang M; Li Y; Lin L; Song G; Deng T
Mol Neurobiol; 2016 Mar; 53(2):1355-1364. PubMed ID: 25633095
[TBL] [Abstract][Full Text] [Related]
23. The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.
Jakubowska A; Rozkrut D; Antoniou A; Hamann U; Lubinski J
Breast Cancer Res Treat; 2010 Jun; 121(3):639-49. PubMed ID: 19876733
[TBL] [Abstract][Full Text] [Related]
24. No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Spurdle AB; Deans AJ; Duffy D; Goldgar DE; Chen X; Beesley J; ; Easton DF; Antoniou AC; Peock S; Cook M; ; Nathanson KL; Domchek SM; MacArthur GA; Chenevix-Trench G
Breast Cancer Res Treat; 2009 May; 115(2):307-13. PubMed ID: 18543099
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies.
Gong M; Dong W; Shi Z; Xu Y; Ni W; An R
PLoS One; 2012; 7(11):e50587. PubMed ID: 23189206
[TBL] [Abstract][Full Text] [Related]
26. [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers].
Rusinova GG; Azizova TV; Viazovskaia NS; Glazkova IV; Gur'ianov MIu; Osovets SV
Radiats Biol Radioecol; 2014; 54(4):350-9. PubMed ID: 25775823
[TBL] [Abstract][Full Text] [Related]
27. The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Kaufman B; Laitman Y; Ziv E; Hamann U; Torres D; Lahad EL; Beeri R; Renbaum P; Jakubowska A; Lubinski J; Huzarski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Sprudle AB; Chenevix-Trench G; Simard J; Easton DF; Antonis A; Szabo C; Friedman E
Breast Cancer Res Treat; 2011 Apr; 126(2):521-7. PubMed ID: 20798986
[TBL] [Abstract][Full Text] [Related]
28. Deletion and Single Nucleotide Polymorphisms in Common Glutathione-S Transferases Contribute to Colorectal Cancer Development.
Stojkovic Lalosevic ML; Coric VM; Pekmezovic TD; Simic TP; Pljesa Ercegovac MS; Pavlovic Markovic AR; Krivokapic ZV
Pathol Oncol Res; 2019 Oct; 25(4):1579-1587. PubMed ID: 30694518
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach.
Tulsyan S; Chaturvedi P; Agarwal G; Lal P; Agrawal S; Mittal RD; Mittal B
Mol Diagn Ther; 2013 Dec; 17(6):371-9. PubMed ID: 23812950
[TBL] [Abstract][Full Text] [Related]
30. Association of GSTM1, GSTT1, GSTP1-ILE105VAL and ACE I/D polymorphisms with ankylosing spondylitis.
İnal EE; Görükmez O; Eroğlu S; Görükmez Ö; Solak Ö; Topak A; Yakut T
Rheumatol Int; 2016 Jan; 36(1):17-23. PubMed ID: 26186891
[TBL] [Abstract][Full Text] [Related]
31. GSTM1, GSTP1, and GSTT1 genetic variability in Turkish and worldwide populations.
Karaca S; Karaca M; Cesuroglu T; Erge S; Polimanti R
Am J Hum Biol; 2015; 27(3):310-6. PubMed ID: 25515186
[TBL] [Abstract][Full Text] [Related]
32. The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patients.
Buchard A; Eefsen M; Semb S; Andersen SE; Morling N; Bendtsen F; Larsen FS; Dalhoff K
Clin Toxicol (Phila); 2012 Jan; 50(1):27-33. PubMed ID: 22175791
[TBL] [Abstract][Full Text] [Related]
33. Detection and relevance of germline genetic polymorphisms in glutathione S-transferases (GSTs) in breast cancer patients from northern Indian population.
Saxena A; Dhillon VS; Raish M; Asim M; Rehman S; Shukla NK; Deo SV; Ara A; Husain SA
Breast Cancer Res Treat; 2009 Jun; 115(3):537-43. PubMed ID: 18574688
[TBL] [Abstract][Full Text] [Related]
34. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Wang X; Pankratz VS; Fredericksen Z; Tarrell R; Karaus M; McGuffog L; Pharaoh PD; Ponder BA; Dunning AM; Peock S; Cook M; Oliver C; Frost D; ; Sinilnikova OM; Stoppa-Lyonnet D; Mazoyer S; Houdayer C; ; Hogervorst FB; Hooning MJ; Ligtenberg MJ; ; Spurdle A; Chenevix-Trench G; ; Schmutzler RK; Wappenschmidt B; Engel C; Meindl A; Domchek SM; Nathanson KL; Rebbeck TR; Singer CF; Gschwantler-Kaulich D; Dressler C; Fink A; Szabo CI; Zikan M; Foretova L; Claes K; Thomas G; Hoover RN; Hunter DJ; Chanock SJ; Easton DF; Antoniou AC; Couch FJ
Hum Mol Genet; 2010 Jul; 19(14):2886-97. PubMed ID: 20418484
[TBL] [Abstract][Full Text] [Related]
35. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Sinilnikova OM; Antoniou AC; Simard J; Healey S; Léoné M; Sinnett D; Spurdle AB; Beesley J; Chen X; ; Greene MH; Loud JT; Lejbkowicz F; Rennert G; Dishon S; Andrulis IL; ; Domchek SM; Nathanson KL; Manoukian S; Radice P; Konstantopoulou I; Blanco I; Laborde AL; Durán M; Osorio A; Benitez J; Hamann U; Hogervorst FB; van Os TA; Gille HJ; ; Peock S; Cook M; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Brewer C; ; Hughes DJ; Coupier I; Giraud S; Coulet F; Colas C; Soubrier F; Rouleau E; Bièche I; Lidereau R; Demange L; Nogues C; Lynch HT; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Sutter C; Deissler H; Schaefer D; Froster UG; ; Aittomäki K; Nevanlinna H; McGuffog L; Easton DF; Chenevix-Trench G; Stoppa-Lyonnet D;
Br J Cancer; 2009 Oct; 101(8):1456-60. PubMed ID: 19707196
[TBL] [Abstract][Full Text] [Related]
36. GSTT1, GSTM1, and GSTP1 polymorphisms as a prognostic factor in women with breast cancer.
Oliveira AL; Oliveira Rodrigues FF; Dos Santos RE; Rozenowicz RL; Barbosa de Melo M
Genet Mol Res; 2014 Jan; 13(2):2521-30. PubMed ID: 24535908
[TBL] [Abstract][Full Text] [Related]
37. GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening.
de Aguiar ES; Giacomazzi J; Schmidt AV; Bock H; Saraiva-Pereira ML; Schuler-Faccini L; Duarte Filho D; dos Santos PA; Giugliani R; Caleffi M; Camey SA; Ashton-Prolla P
Rev Bras Epidemiol; 2012 Jun; 15(2):246-55. PubMed ID: 22782090
[TBL] [Abstract][Full Text] [Related]
38. Impact of GSTM1, GSTT1 and GSTP1 gene polymorphism and risk of ARV-associated hepatotoxicity in HIV-infected individuals and its modulation.
Singh HO; Lata S; Angadi M; Bapat S; Pawar J; Nema V; Ghate MV; Sahay S; Gangakhedkar RR
Pharmacogenomics J; 2017 Jan; 17(1):53-60. PubMed ID: 26667829
[TBL] [Abstract][Full Text] [Related]
39. Role of polymorphisms of GSTM1, GSTT1 and GSTP1 Ile105Val in Hodgkin and non-Hodgkin lymphoma risk: a Human Genome Epidemiology (HuGE) review.
Bin Q; Luo J
Leuk Lymphoma; 2013 Jan; 54(1):14-20. PubMed ID: 22734843
[TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans.
Martínez C; Martín F; Fernández JM; García-Martín E; Sastre J; Díaz-Rubio M; Agúndez JA; Ladero JM
Pharmacogenomics; 2006 Jul; 7(5):711-8. PubMed ID: 16886896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
